SORBS2 and ovarian cancer: PI/Annexin V flow cytometry analysis also revealed that the apoptosis rate in the metastasized tissues in the SORBS2-knockdown group was significantly lower than that in the control group (Additional file 2: Figure S8c), revealing an apoptosis resistance-promoting role of SORBS2 knockdown in ovarian cancer.